Quick Take: Mindmed will be collaborating with Forian to use real-world evidence information to help better make decisions for psychiatric patients. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), a leading biotech company developing psychedelic-inspired therapies, has agreed to work with Forian Inc. (NASDAQ: FORA), a leading provider of evidence-based support for more comprehensive clinical…